Recent Finacing
Recent Raise
Fedora Pharmaceuticals develops and advances antimicrobial drug candidates, including beta-lactamase inhibitors, partnering with government and industry to progress compounds into preclinical development from its Edmonton base.
Focus Areas
Recent Investors
Funding round
Investor